{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:45:17Z","timestamp":1790081117544,"version":"4.0.1"},"reference-count":30,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T00:00:00Z","timestamp":1565827200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2015\/18\/E\/NZ3\/00501"],"award-info":[{"award-number":["2015\/18\/E\/NZ3\/00501"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Fibroblast growth factor 1 (FGF1) has been shown to interact with integrin \u03b1v\u03b23 through a specific binding site, involving Arg35 residue. The FGF1 mutant (R35E) with impaired integrin binding was found to be defective in its proliferative response, although it was still able to interact with FGF receptors (FGFR) and heparin and induce the activation of downstream signaling pathways. Here, we demonstrate that the lack of mitogenic potential of R35E mutant is directly caused by its decreased thermodynamic stability and susceptibility to proteolytic degradation. Introduction of three stabilizing mutations into R35E variant compensated the effect of destabilizing R35E mutation and restored the proliferation potential of FGF1. Moreover, the stabilized R35E variant regained both anti-apoptotic and wound healing activities, while remaining defective in binding to integrin \u03b1v\u03b23. Our results suggest that the thermodynamic stability and resistance to degradation, rather than the interaction with integrin are required for mitogenic response of FGF1.<\/jats:p>","DOI":"10.3390\/cells8080899","type":"journal-article","created":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T11:11:00Z","timestamp":1565867460000},"page":"899","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Low Stability of Integrin-Binding Deficient Mutant of FGF1 Restricts Its Biological Activity"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0574-1476","authenticated-orcid":false,"given":"Anna","family":"Szlachcic","sequence":"first","affiliation":[{"name":"Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, 50-383 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1822-4198","authenticated-orcid":false,"given":"Martyna","family":"Sochacka","sequence":"additional","affiliation":[{"name":"Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, 50-383 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8518-7075","authenticated-orcid":false,"given":"Aleksandra","family":"Czyrek","sequence":"additional","affiliation":[{"name":"Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, 50-383 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukasz","family":"Opalinski","sequence":"additional","affiliation":[{"name":"Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, 50-383 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2856-218X","authenticated-orcid":false,"given":"Daniel","family":"Krowarsch","sequence":"additional","affiliation":[{"name":"Department of Protein Biotechnology, Faculty of Biotechnology, University of Wroclaw, 50-383 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8630-2891","authenticated-orcid":false,"given":"Jacek","family":"Otlewski","sequence":"additional","affiliation":[{"name":"Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, 50-383 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8214-1533","authenticated-orcid":false,"given":"Malgorzata","family":"Zakrzewska","sequence":"additional","affiliation":[{"name":"Department of Protein Engineering, Faculty of Biotechnology, University of Wroclaw, 50-383 Wroclaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,8,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd2792","article-title":"The FGF family: Biology, pathophysiology and therapy","volume":"8","author":"Beenken","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The Fibroblast Growth Factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: From development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrm3528","article-title":"Exploring mechanisms of FGF signalling through the lens of structural biology","volume":"14","author":"Goetz","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Zinkle, A., and Mohammadi, M. (2018). A threshold model for receptor tyrosine kinase signaling specificity and cell fate determination. F1000Res., 7.","DOI":"10.12688\/f1000research.14143.1"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"18066","DOI":"10.1074\/jbc.M801213200","article-title":"Direct binding of integrin alphavbeta3 to FGF1 plays a role in FGF1 signaling","volume":"283","author":"Mori","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Yamaji, S., Saegusa, J., Ieguchi, K., Fujita, M., Mori, S., Takada, Y.K., and Takada, Y. (2010). A novel fibroblast growth factor-1 (FGF1) mutant that acts as an FGF antagonist. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010273"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1161\/hh2401.101084","article-title":"Integrin and growth factor receptor crosstalk","volume":"89","author":"Eliceiri","year":"2001","journal-title":"Circ. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-cellbio-092910-154017","article-title":"Cooperation between integrins and growth factor receptors in signaling and endocytosis","volume":"27","author":"Ivaska","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2748","article-title":"Integrins in cancer: Biological implications and therapeutic opportunities","volume":"10","author":"Desgrosellier","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Mori, S., Tran, V., Nishikawa, K., Kaneda, T., Hamada, Y., Kawaguchi, N., Fujita, M., Saegusa, J., Takada, Y.K., and Matsuura, N. (2013). A dominant-negative FGF1 mutant (the R50E mutant) suppresses tumorigenesis and angiogenesis. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0057927"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/267274a0","article-title":"Effect of a single amino acid substitution on stability of conformation of a protein","volume":"267","author":"Yutani","year":"1977","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"D120","DOI":"10.1093\/nar\/gkh082","article-title":"ProTherm, version 4.0: Thermodynamic database for proteins and mutants","volume":"32","author":"Bava","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"25388","DOI":"10.1074\/jbc.M109.001289","article-title":"Increased protein stability of FGF1 can compensate for its reduced affinity for heparin","volume":"284","author":"Zakrzewska","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1007\/s00018-015-1856-8","article-title":"Instability restricts signaling of multiple fibroblast growth factors","volume":"72","author":"Buchtova","year":"2015","journal-title":"Cell Mol. Life Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jmb.2005.07.066","article-title":"Highly stable mutants of human fibroblast growth factor-1 exhibit prolonged biological action","volume":"352","author":"Zakrzewska","year":"2005","journal-title":"J. Mol. Biol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/protein\/gzh076","article-title":"Design of fully active FGF-1 variants with increased stability","volume":"17","author":"Zakrzewska","year":"2004","journal-title":"Protein Eng. Des. Sel."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0006-291X(86)80540-X","article-title":"The complete amino acid sequence of human brain-derived acidic fibroblast growth factor","volume":"138","author":"Conn","year":"1986","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pep.2014.03.012","article-title":"Efficient production and purification of extracellular domain of human FGFR-Fc fusion proteins from Chinese hamster ovary cells","volume":"99","author":"Borek","year":"2014","journal-title":"Protein Expr. Purif."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1172\/JCI29884","article-title":"Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism","volume":"117","author":"Pitteloud","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/nature13540","article-title":"Endocrinization of FGF1 produces a neomorphic and potent insulin sensitizer","volume":"513","author":"Suh","year":"2014","journal-title":"Nature"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1126\/science.7536345","article-title":"FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides","volume":"268","author":"Ornitz","year":"1995","journal-title":"Science"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cytogfr.2005.01.001","article-title":"Cellular signaling by fibroblast growth factor receptors","volume":"16","author":"Eswarakumar","year":"2005","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1128\/MCB.24.13.5657-5666.2004","article-title":"The docking protein Gab1 is an essential component of an indirect mechanism for fibroblast growth factor stimulation of the phosphatidylinositol 3-kinase\/Akt antiapoptotic pathway","volume":"24","author":"Lamothe","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/excr.1994.1353","article-title":"Cell cycle-dependent nuclear localization of exogenously added fibroblast growth factor-1 in BALB\/c 3T3 and human vascular endothelial cells","volume":"215","author":"Imamura","year":"1994","journal-title":"Exp. Cell Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M","article-title":"FGFs, heparan sulfate and FGFRs: Complex interactions essential for development","volume":"22","author":"Ornitz","year":"2000","journal-title":"Bioessays"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1182\/blood-2016-02-702373","article-title":"Protein stabilization improves STAT3 function in autosomal dominant hyper-IgE syndrome","volume":"128","author":"Bocchini","year":"2016","journal-title":"Blood"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1073\/pnas.1102198108","article-title":"Missense mutations in the NF2 gene result in the quantitative loss of merlin protein and minimally affect protein intrinsic function","volume":"108","author":"Yang","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0092-8674(00)80851-X","article-title":"Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity","volume":"101","author":"Plotnikov","year":"2000","journal-title":"Cell"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"16305","DOI":"10.1016\/S0021-9258(18)42001-7","article-title":"Ligand specificity and heparin dependence of fibroblast growth factor receptors 1 and 3","volume":"267","author":"Ornitz","year":"1992","journal-title":"J. Biol. Chem."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/8\/899\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:11:15Z","timestamp":1760188275000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/8\/8\/899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,15]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2019,8]]}},"alternative-id":["cells8080899"],"URL":"https:\/\/doi.org\/10.3390\/cells8080899","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,15]]}}}